Moreover, our findings illustrate that treatment with (S)-PHA533533 increases UBE3A protein levels in mature iPSC-derived human neurons from an Angelman syndrome patient (ASdel1-0 neurons), as confirmed through western blot and immunocytochemistry assays (Supplementary Fig. 3). This evidence concerns the gene UBE3A and Angelman syndrome.